Development of Personalized Health Care Service in Patients With Breast Cancer

June 20, 2017 updated by: Eun Joo Yang, Seoul National University Bundang Hospital
In order to develop effective personalized healthcare service program for breast cancer rehabilitation, we designed this study using mobile phone and clinical intervention(feedback coaching).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Breast cancer patient (age over 18), Cancer stage under 3, Android OS smartphone user

Exclusion Criteria:

  • Cancer stage over 4, Patients diagnosed with multiple cancer, Patient who can not participate rehabilitation exercise program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Breast cancer patients
Behavioral: Personalized health care service
Physical activity coaching, other functional outcome observation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction change
Time Frame: Baseline and after 2 weeks, 4 weeks of lifestyle modification
Patient subjective evaluation by survey on satisfaction
Baseline and after 2 weeks, 4 weeks of lifestyle modification

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity change
Time Frame: Baseline and after 2 weeks, 4 weeks of lifestyle modification
Physical activity measurement by step count
Baseline and after 2 weeks, 4 weeks of lifestyle modification
Functional outcome change
Time Frame: Baseline and after 2 weeks, 4 weeks of lifestyle modification
(Physical)Functional outcome measurement by breast cancer patient questionnaire
Baseline and after 2 weeks, 4 weeks of lifestyle modification
Quality of care change
Time Frame: Baseline and after 2 weeks, 4 weeks of lifestyle modification
Quality of care measurement by breast cancer patient questionnaire
Baseline and after 2 weeks, 4 weeks of lifestyle modification

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Seoul National University Bundang Hospital

Investigators

  • Study Chair: Eunjoo Yang, PhD, Seoul National University Bundang Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 27, 2015

Primary Completion (Actual)

February 15, 2016

Study Completion (Actual)

February 22, 2016

Study Registration Dates

First Submitted

June 7, 2017

First Submitted That Met QC Criteria

June 20, 2017

First Posted (Actual)

June 21, 2017

Study Record Updates

Last Update Posted (Actual)

June 21, 2017

Last Update Submitted That Met QC Criteria

June 20, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • E-1509-314-002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe